What Will Happen to Syneos Health Inc – Class A (NASDAQ:SYNH) Next? The Stock Has Decline in Shorts

September 30, 2018 - By Mary Kidd

The stock of Syneos Health Inc – Class A (NASDAQ:SYNH) registered a decrease of 3.23% in short interest. SYNH’s total short interest was 5.61 million shares in September as published by FINRA. Its down 3.23% from 5.79M shares, reported previously. With 508,900 shares average volume, it will take short sellers 11 days to cover their SYNH’s short positions. The short interest to Syneos Health Inc – Class A’s float is 9.18%.

The stock increased 1.08% or $0.55 during the last trading session, reaching $51.55. About 508,676 shares traded. Syneos Health, Inc. (NASDAQ:SYNH) has declined 12.82% since September 30, 2017 and is downtrending. It has underperformed by 28.44% the S&P500.

Syneos Health, Inc. operates as an integrated biopharmaceutical solutions firm in North America, Europe, the Middle East, Africa, the Asia-Pacific, and Latin America. The company has market cap of $5.31 billion. It operates through two divisions, Clinical Solutions and Commercial Solutions. It currently has negative earnings. The Clinical Solutions segment offers various clinical development services spanning Phase I to Phase IV, including full-service global studies, as well as unbundled service offerings, such as clinical monitoring, investigator recruitment, patient recruitment, data management, and study startup to assist clients with drug development process.

Syneos Health, Inc. (NASDAQ:SYNH) Ratings Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: